Jan
17
6 Third-Party Payers Settle Zyprexa Claims For $ 4.5M Amount After Class Vacated
January 17, 2012 | Leave a Comment
BROOKLYN, NY – The Zyprexa multidistrict litigation judge on Jan. 12 approved a $ 4.5 million settlement between Eli Lilly and Co. and six third-party payers who had their Racketeer Influenced and Corrupt Organizations (RICO) Act class action vacated and who couldn’t find any other health benefit providers to join their individual suits, the parties told Mealey Publications (In Re: Zyprexa Products Liability Litigation, MDL Docket No. 1596, No. 04-md-1596, UFCW Local 1776 v. Eli Lilly and Company, Nos. 05-5115, E.D. N.Y.).
LexisNexis® Mealey’s™ Daily Legal News